Orthopedic Devices are used to treat the disorders and injuries of the musculoskeletal system of human body. The Ankle Replacement includes Total Ankle Replacement, which is typically carried out to treat ankle arthritis. GlobalData uses proprietary data and analytics to provide a comprehensive report on the ankle replacement devices market, including market shares of different players within Norway. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the ankle replacement market in Norway was Stryker followed by Integra LifeSciences, Exactech and Zimmer Biomet.
Total Ankle Replacement is a replacement intervention that involves replacing the severely damaged or inflamed parts of bones and cartilage of the ankle joint with a prosthetic device/implant. Total Ankle Replacement intervention reduces pain while retrieving mobility and function of the ankle joint.
The value of the ankle replacement devices market within Norway was expected to be over $0.1m in 2023.
For the latest complete market share analysis of ankle replacement device market in Norway, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
